← Back to headlines
ANI Pharmaceuticals Targets Over $1 Billion in 2026 Revenue
ANI Pharmaceuticals aims to achieve over $1 billion in revenue by 2026, focusing on rare disease treatments and expanding its sales force.
27 Feb, 17:58 — 27 Feb, 17:58
ℹOnly 1 source covers this story
Read at source (1 outlet)
Related Stories
LTFRB suspends 3 transport network firms for violations
just now
European Parliament Proposes Measures to Address EU Housing Shortage and Construction Bureaucracy
7m ago
Rent tops £1,000 a month in more areas - find out where
11m ago
Spain Sees Over 127,000 New Companies in 2025, Featuring Original Names
20m ago